Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
Publisher Name » GBI Research
Published Date » 2010-11-15
No. Of Pages » 65
GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in india. The report provides market landscape, competitive landscape and market trends information on the segments within the analytical services market. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, services technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
- Key geographies covered is India
- Market size and company share data the segments with pharmaceutical anlaytical laboratories market
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the pharmaceutical analytical services market.
- The report also covers information on the leading market players, the competitive landscape, services and technologies.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the Indian pharmaceutical analytical services market.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the promising products
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the pharmaceutical analytical services market? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the Indian pharmaceutical analytical services market and the factors shaping it.
Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 GBI Research Report Guidance 8
3 Background: 9
3.1 Major Services under Pharmaceutical Analytical Services 10
3.1.1 Impurity Profile 10
3.1.2 Analytical Method Development and Validations 10
3.1.3 Particle Size Distribution 10
4 Pharmaceutical Drug Discovery Outsourcing Market: Market Characterization 11
4.1 Market Share and Market Size 11
4.2 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
4.3 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
4.4 Forces that Drive Drug Discovery in India and China 14
4.4.1 Declining R&D Productivity, Especially for Big Pharma 14
5 Outsourcing Plan for Pharmaceutical Companies 16
5.1 Why India and China? 18
5.1.1 Availability of Skilled Manpower 18
5.1.2 Improved IP Protection in India and China 19
5.1.3 Government Support for Drug Discovery Development 20
5.1.4 SWOT Analysis of the Drug Discovery Industry in India 22
5.1.5 Conclusion 23
6 IP Protection in India and China Improved IP Protection to Encourage Innovation 24
6.1 Patent Act 2005 First Step towards Improving IP Protection 25
6.2 IPR Enforcement Rules, 2007 26
6.3 Trademarks Bill 2007 26
6.4 Drugs and Cosmetics Act (Amendment) 2008 27
6.5 EIPR (Enforcers of Intellectual Property Rights) Ensuring IPR Laws Implementation in India 27
7 Government and Regulatory Support in India Strong Support to Research Institutes and Small Companies 29
7.1 Government/Regulatory Support for Drug Discovery in India 29
7.1.1 Open Source Drug Discovery 29
7.1.2 Drug Development Promotion Board: Encouraging a PPP Model for Drug Discovery and Development 30
7.1.3 Technology Development Board: Supporting Technology Oriented Projects 31
7.1.4 NMITLI (New Millennium Indian Technology Leadership Initiative) Scheme 32
8 Pharmaceutical Analytical Services Outsourcing Market, Market Dynamics 33
8.1 Pharmaceutical Analytical Services Outsourcing Market, Market Trends 33
8.1.1 Pricing Pressures Driving Outsourcing of Pharmaceutical Analytical Work to Low Cost Destinations 33
8.1.2 Flexibility Offered by Companies in Terms of Resource and Manpower Allocation Contributing Towards Increased Outsourcing 33
8.1.3 Shared Risk Concept Encourages Greater Outsourcing of Drug Development 33
8.2 Pharmaceutical Analytical Services Outsourcing Market, Market Drivers 33
8.2.1 Lower Cost is a Key Driver towards Chemistry Outsourcing to Asian CROs 33
8.2.2 Demand for Shorter Research Cycle Driving Outsourcing of Chemistry Services 34
8.3 Pharmaceutical Analytical Services Outsourcing Market, Market Restraints 34
8.3.1 Intellectual Property and Legal Landscape is a Key Restraint in the Growth of Outsourcing of Pharmaceutical Analytical Services to Asian Countries 34
9 Market Opportunity and Risk Assesment 35
10 Future Outlook 36
11 Major Indian Drug Discovery Companies Different Business Models to Provide Similar Services 38
11.1 Indian Drug Discovery Business Model R&D Hive-off for Better Services and Risk Reduction 38
11.2 Jubilant Organosys Jubilant Biosys 39
11.2.1 About Jubilant Organosys 39
11.2.2 Major Drug Discovery Deals 40
11.3 Dr. Reddys Aurigene 41
11.3.1 About Dr. Reddys 41
11.3.2 Aurigene 41
11.3.3 Major Drug Discovery Deals 42
11.4 Biocons Syngene 43
11.4.1 About Biocon 43
11.4.2 Syngene 43
11.4.3 Major Drug Discovery Deals 44
11.5 GVK BIO 45
11.5.1 Business Description 45
11.5.2 Major Drug Discovery Deals 46
11.6 Advinus Therapeutics 47
11.6.1 Business Description 47
11.6.2 Major Drug Discovery Deals 48
11.7 Sipra Labs 49
11.7.1 Business Description 49
11.8 Sai Advantium 50
11.8.1 Business Description 50
12 Deals Analysis Equal Thrust From Big Pharma and Mid-Size Pharma 51
12.1 Number of Discovery Research Deals Increased Activity by Big and Mid-size Pharma 51
12.2 Deals by Major Therapeutic Area Oncology and Metabolic Disorders 52
12.3 Deals by Client Type Mid-size Pharma Deals Rising in India and China 53
12.4 Major Drug Discovery Deals 55
12.4.1 Amgen with Jubilant Biosys: Supporting Early Stage Preclinical Development Effort to Provide Cost-Effective Drugs 55
12.4.2 Bristol-Myers Squibb with Syngene: Dedicated Research Facility for Discovery and Early Drug Development 55
12.4.3 Novartis with Aurigene: Generating Pre-clinical Candidates for Oncology-focused Program 55
12.4.4 Merck & Co with Advinus Therapeutics: To Develop Clinically Validated Drug Candidates for Metabolic Disorders 55
12.5 Conclusion 56
13 Future Challenges Financial and Intellectual Obstacles to Impede the Future Growth 57
13.1 Financial Problems will Make it Difficult to Sustain the Growth 57
13.2 Talent Shortage in Early Stage Chemistry and Biology 57
13.3 Competition from Europe as an Alternative Discovery Research Destination 58
13.4 Conclusion 59
14 Key Takeaway 60
15 Appendix 61
15.1 Definitions 61
15.2 Market Definitions 61
15.3 Acronyms 61
15.4 Research Methodology 64
15.4.1 Secondary Research 64
15.4.2 Primary Research 64
15.4.3 Models 65
15.4.4 Forecasts 65
15.4.5 Expert Panels 65
15.5 Contact Us 65
15.6 Disclaimer 65
Table 1: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
Table 2: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
Table 3: SWOT Analysis Drug Discovery Market in India 22
Figure 1: Drug Discovery Research 7
Figure 2: Fully Integrated Pharmaceutical Network 9
Figure 3: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
Figure 4: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
Figure 5: Global Drug Discovery Market, Market Breakdown by Value, 2008 13
Figure 6: Comparison of CAGR of R&D Expenditure versus Turnover for the Top 5 Pharmaceutical Companies, 20042008 14
Figure 7: Increasing Cost of Introducing an NME in the US 15
Figure 8: Outsourcing Map for Pharmaceutical Companies 16
Figure 9: Different Types of Cooperation Models for Outsourced Services 17
Figure 10: India & China Talent Pool Comparison 18
Figure 11: Number of Patent Applications Originating from China and India, 20042008 24
Figure 12: Intellectual Property Rights in India 25
Figure 13: Open Source Drug Discovery Activity Map 30
Figure 14: Technology Development Board Financial Assistance, India, Value Breakdown by Sector, 19972007 31
Figure 15: Traditional Outsourcing Model 36
Figure 16: Strategic Partnership Model 37
Figure 17: Business Models, Indian Drug Discovery Companies 38
Figure 18: Jubilant Corporate Profile 39
Figure 19: Dr. Reddys Corporate Profile 41
Figure 20: Biocon Corporate Profile 43
Figure 21: GVK BIO Corporate Profile 45
Figure 22: Advinus Therapeutics Corporate Profile 47
Figure 23: Sipra Labs - Corporate Profile 49
Figure 24: Sai Advantium - Corporate Profile 50
Figure 25: Number of Major Discovery Research Deals by Country, India and China, 20062009 51
Figure 26: Percentage of Major Discovery Research Deals by Therapeutic Area, India and China, 20062009 52
Figure 27: Number of Major Discovery Research Deals in India and China by Client Company Type, 20062009 53
Figure 28: Top 5 Big Pharma Companies by Number of Deals in India and China, 20062009 54
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 GBI Research Report Guidance 8
3 Background: 9
3.1 Major Services under Pharmaceutical Analytical Services 10
3.1.1 Impurity Profile 10
3.1.2 Analytical Method Development and Validations 10
3.1.3 Particle Size Distribution 10
4 Pharmaceutical Drug Discovery Outsourcing Market: Market Characterization 11
4.1 Market Share and Market Size 11
4.2 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
4.3 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
4.4 Forces that Drive Drug Discovery in India and China 14
4.4.1 Declining R&D Productivity, Especially for Big Pharma 14
5 Outsourcing Plan for Pharmaceutical Companies 16
5.1 Why India and China? 18
5.1.1 Availability of Skilled Manpower 18
5.1.2 Improved IP Protection in India and China 19
5.1.3 Government Support for Drug Discovery Development 20
5.1.4 SWOT Analysis of the Drug Discovery Industry in India 22
5.1.5 Conclusion 23
6 IP Protection in India and China Improved IP Protection to Encourage Innovation 24
6.1 Patent Act 2005 First Step towards Improving IP Protection 25
6.2 IPR Enforcement Rules, 2007 26
6.3 Trademarks Bill 2007 26
6.4 Drugs and Cosmetics Act (Amendment) 2008 27
6.5 EIPR (Enforcers of Intellectual Property Rights) Ensuring IPR Laws Implementation in India 27
7 Government and Regulatory Support in India Strong Support to Research Institutes and Small Companies 29
7.1 Government/Regulatory Support for Drug Discovery in India 29
7.1.1 Open Source Drug Discovery 29
7.1.2 Drug Development Promotion Board: Encouraging a PPP Model for Drug Discovery and Development 30
7.1.3 Technology Development Board: Supporting Technology Oriented Projects 31
7.1.4 NMITLI (New Millennium Indian Technology Leadership Initiative) Scheme 32
8 Pharmaceutical Analytical Services Outsourcing Market, Market Dynamics 33
8.1 Pharmaceutical Analytical Services Outsourcing Market, Market Trends 33
8.1.1 Pricing Pressures Driving Outsourcing of Pharmaceutical Analytical Work to Low Cost Destinations 33
8.1.2 Flexibility Offered by Companies in Terms of Resource and Manpower Allocation Contributing Towards Increased Outsourcing 33
8.1.3 Shared Risk Concept Encourages Greater Outsourcing of Drug Development 33
8.2 Pharmaceutical Analytical Services Outsourcing Market, Market Drivers 33
8.2.1 Lower Cost is a Key Driver towards Chemistry Outsourcing to Asian CROs 33
8.2.2 Demand for Shorter Research Cycle Driving Outsourcing of Chemistry Services 34
8.3 Pharmaceutical Analytical Services Outsourcing Market, Market Restraints 34
8.3.1 Intellectual Property and Legal Landscape is a Key Restraint in the Growth of Outsourcing of Pharmaceutical Analytical Services to Asian Countries 34
9 Market Opportunity and Risk Assesment 35
10 Future Outlook 36
11 Major Indian Drug Discovery Companies Different Business Models to Provide Similar Services 38
11.1 Indian Drug Discovery Business Model R&D Hive-off for Better Services and Risk Reduction 38
11.2 Jubilant Organosys Jubilant Biosys 39
11.2.1 About Jubilant Organosys 39
11.2.2 Major Drug Discovery Deals 40
11.3 Dr. Reddys Aurigene 41
11.3.1 About Dr. Reddys 41
11.3.2 Aurigene 41
11.3.3 Major Drug Discovery Deals 42
11.4 Biocons Syngene 43
11.4.1 About Biocon 43
11.4.2 Syngene 43
11.4.3 Major Drug Discovery Deals 44
11.5 GVK BIO 45
11.5.1 Business Description 45
11.5.2 Major Drug Discovery Deals 46
11.6 Advinus Therapeutics 47
11.6.1 Business Description 47
11.6.2 Major Drug Discovery Deals 48
11.7 Sipra Labs 49
11.7.1 Business Description 49
11.8 Sai Advantium 50
11.8.1 Business Description 50
12 Deals Analysis Equal Thrust From Big Pharma and Mid-Size Pharma 51
12.1 Number of Discovery Research Deals Increased Activity by Big and Mid-size Pharma 51
12.2 Deals by Major Therapeutic Area Oncology and Metabolic Disorders 52
12.3 Deals by Client Type Mid-size Pharma Deals Rising in India and China 53
12.4 Major Drug Discovery Deals 55
12.4.1 Amgen with Jubilant Biosys: Supporting Early Stage Preclinical Development Effort to Provide Cost-Effective Drugs 55
12.4.2 Bristol-Myers Squibb with Syngene: Dedicated Research Facility for Discovery and Early Drug Development 55
12.4.3 Novartis with Aurigene: Generating Pre-clinical Candidates for Oncology-focused Program 55
12.4.4 Merck & Co with Advinus Therapeutics: To Develop Clinically Validated Drug Candidates for Metabolic Disorders 55
12.5 Conclusion 56
13 Future Challenges Financial and Intellectual Obstacles to Impede the Future Growth 57
13.1 Financial Problems will Make it Difficult to Sustain the Growth 57
13.2 Talent Shortage in Early Stage Chemistry and Biology 57
13.3 Competition from Europe as an Alternative Discovery Research Destination 58
13.4 Conclusion 59
14 Key Takeaway 60
15 Appendix 61
15.1 Definitions 61
15.2 Market Definitions 61
15.3 Acronyms 61
15.4 Research Methodology 64
15.4.1 Secondary Research 64
15.4.2 Primary Research 64
15.4.3 Models 65
15.4.4 Forecasts 65
15.4.5 Expert Panels 65
15.5 Contact Us 65
15.6 Disclaimer 65
List of Tables
Table 1: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
Table 2: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
Table 3: SWOT Analysis Drug Discovery Market in India 22
List of Figures
Figure 1: Drug Discovery Research 7
Figure 2: Fully Integrated Pharmaceutical Network 9
Figure 3: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
Figure 4: Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
Figure 5: Global Drug Discovery Market, Market Breakdown by Value, 2008 13
Figure 6: Comparison of CAGR of R&D Expenditure versus Turnover for the Top 5 Pharmaceutical Companies, 20042008 14
Figure 7: Increasing Cost of Introducing an NME in the US 15
Figure 8: Outsourcing Map for Pharmaceutical Companies 16
Figure 9: Different Types of Cooperation Models for Outsourced Services 17
Figure 10: India & China Talent Pool Comparison 18
Figure 11: Number of Patent Applications Originating from China and India, 20042008 24
Figure 12: Intellectual Property Rights in India 25
Figure 13: Open Source Drug Discovery Activity Map 30
Figure 14: Technology Development Board Financial Assistance, India, Value Breakdown by Sector, 19972007 31
Figure 15: Traditional Outsourcing Model 36
Figure 16: Strategic Partnership Model 37
Figure 17: Business Models, Indian Drug Discovery Companies 38
Figure 18: Jubilant Corporate Profile 39
Figure 19: Dr. Reddys Corporate Profile 41
Figure 20: Biocon Corporate Profile 43
Figure 21: GVK BIO Corporate Profile 45
Figure 22: Advinus Therapeutics Corporate Profile 47
Figure 23: Sipra Labs - Corporate Profile 49
Figure 24: Sai Advantium - Corporate Profile 50
Figure 25: Number of Major Discovery Research Deals by Country, India and China, 20062009 51
Figure 26: Percentage of Major Discovery Research Deals by Therapeutic Area, India and China, 20062009 52
Figure 27: Number of Major Discovery Research Deals in India and China by Client Company Type, 20062009 53
Figure 28: Top 5 Big Pharma Companies by Number of Deals in India and China, 20062009 54
Upcoming Reports:
|
Lighting Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Lighting equipment could be mundanely understood as the equipment responsible for the production of light energy. With an ever increasing rise in the global population, and the rising awareness amongst us to protect our mother earth, lighting equipment market is experiencing a healthy growth rate.
Rising global population, rising urbanization rate, invention of innovative products such as LED, rising go green initiatives, are some of the drivers of the lighting equipment market. The rising economies of the Asia Pacific countries, will serve as an opportunity for the lighting...
|
|
Knee Implants Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Knee implant procedures are done when a patient has knee pain, a traumatic injury or a disability from rheumatoid arthritis, or osteoarthritis. In the surgical process, a surgeon implants the device (artificial device) and replaces the damaged knee with it. There are many different types of implants - which are made of metal alloys, strong plastic parts or ceramic material.
The knee implants market will grow due to factors such as increase in the rate of age related diseases like osteoporosis and arthritis, diabetes, obesity, ageing population and injuries related...
|
|
Set-Top Boxes Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The worldwide market for set top boxes is expected to experience significant growth rate in the near future as a result of technological advancements and better quality of signal transmission. Asia Pacific and Latin America markets are expected to witness double digit growth rate in this market as subscribers are gaining access to pay TV platforms for the very first time.
Shaken by the economic slowdown, set top boxes market noted slow growth rate in past few years; however, the condition is significantly changing with many new manufacturers emerging in the market,...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Latest Reports
- The Future of the Wine Market in Indonesia to 2017
- The Future of the Wine Market in Hungary to 2017
- The Future of the Wine Market in Hong Kong to 2017
- The Future of the Wine Market in Greece to 2017
- The Future of the Wine Market in Finland to 2017
- The Future of the Wine Market in Egypt to 2017
- The Future of the Wine Market in Denmark to 2017
- The Future of the Wine Market in Czech Republic to 2017
- The Future of the Wine Market in the United Kingdom to 2017
- Switzerland Quarterly Beverage Tracker Report Q1 2013
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
